Scienture (SCNX) Competitors

$0.39 0.00 (-0.91%)

Closing price 04:00 PM Eastern

Extended Trading

$0.39 +0.00 (+0.51%)

As of 07:19 PM Eastern

SCNX vs. RAVE, LTCH, UFG, NHTC, and CGTL

Should you buy Scienture stock or one of its competitors? MarketBeat compares Scienture with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Scienture include Rave Restaurant Group (RAVE), Latch (LTCH), Uni-Fuels (UFG), Natural Health Trends (NHTC), and Creative Global Technology (CGTL). These companies are all part of the "wholesale" industry.

How does Scienture compare to Rave Restaurant Group?

Rave Restaurant Group (NASDAQ:RAVE) and Scienture (NASDAQ:SCNX) are both small-cap wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

15.1% of Rave Restaurant Group shares are held by institutional investors. Comparatively, 5.7% of Scienture shares are held by institutional investors. 28.0% of Rave Restaurant Group shares are held by insiders. Comparatively, 21.4% of Scienture shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Rave Restaurant Group has higher revenue and earnings than Scienture. Scienture is trading at a lower price-to-earnings ratio than Rave Restaurant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rave Restaurant Group	$12.04M	3.25	$2.70M	$0.21	13.10
Scienture	$430K	36.85	-$41.51M	-$2.51	N/A

Rave Restaurant Group has a net margin of 23.19% compared to Scienture's net margin of 0.00%. Rave Restaurant Group's return on equity of 19.22% beat Scienture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rave Restaurant Group	23.19%	19.22%	16.81%
Scienture	N/A	-56.28%	-44.76%

Rave Restaurant Group has a beta of 0.39, indicating that its share price is 61% less volatile than the broader market. Comparatively, Scienture has a beta of 3.32, indicating that its share price is 232% more volatile than the broader market.

Scienture has a consensus price target of $1.50, suggesting a potential upside of 284.62%. Given Scienture's higher probable upside, analysts clearly believe Scienture is more favorable than Rave Restaurant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rave Restaurant Group	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Scienture	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Scienture had 2 more articles in the media than Rave Restaurant Group. MarketBeat recorded 2 mentions for Scienture and 0 mentions for Rave Restaurant Group. Rave Restaurant Group's average media sentiment score of 0.80 beat Scienture's score of 0.75 indicating that Rave Restaurant Group is being referred to more favorably in the media.

Company	Overall Sentiment
Rave Restaurant Group	Positive
Scienture	Positive

Summary

Rave Restaurant Group beats Scienture on 10 of the 15 factors compared between the two stocks.

How does Scienture compare to Latch?

Latch (NASDAQ:LTCH) and Scienture (NASDAQ:SCNX) are both small-cap wholesale companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

Scienture has lower revenue, but higher earnings than Latch. Latch is trading at a lower price-to-earnings ratio than Scienture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Latch	$48.39M	0.61	-$162.34M	-$0.31	N/A
Scienture	$430K	36.85	-$41.51M	-$2.51	N/A

Latch's return on equity of 0.00% beat Scienture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Latch	N/A	N/A	N/A
Scienture	N/A	-56.28%	-44.76%

Scienture has a consensus price target of $1.50, suggesting a potential upside of 284.62%. Given Scienture's stronger consensus rating and higher probable upside, analysts clearly believe Scienture is more favorable than Latch.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Latch	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Scienture	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

0.4% of Latch shares are held by institutional investors. Comparatively, 5.7% of Scienture shares are held by institutional investors. 27.5% of Latch shares are held by company insiders. Comparatively, 21.4% of Scienture shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Latch has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market. Comparatively, Scienture has a beta of 3.32, indicating that its stock price is 232% more volatile than the broader market.

In the previous week, Scienture had 1 more articles in the media than Latch. MarketBeat recorded 2 mentions for Scienture and 1 mentions for Latch. Scienture's average media sentiment score of 0.75 beat Latch's score of 0.00 indicating that Scienture is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Latch	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Scienture	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Scienture beats Latch on 10 of the 15 factors compared between the two stocks.

How does Scienture compare to Uni-Fuels?

Uni-Fuels (NASDAQ:UFG) and Scienture (NASDAQ:SCNX) are both small-cap wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

In the previous week, Scienture had 2 more articles in the media than Uni-Fuels. MarketBeat recorded 2 mentions for Scienture and 0 mentions for Uni-Fuels. Uni-Fuels' average media sentiment score of 1.87 beat Scienture's score of 0.75 indicating that Uni-Fuels is being referred to more favorably in the media.

Company	Overall Sentiment
Uni-Fuels	Very Positive
Scienture	Positive

5.7% of Scienture shares are owned by institutional investors. 21.4% of Scienture shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Uni-Fuels has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Scienture has a beta of 3.32, meaning that its stock price is 232% more volatile than the broader market.

Uni-Fuels' return on equity of 0.00% beat Scienture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Uni-Fuels	N/A	N/A	N/A
Scienture	N/A	-56.28%	-44.76%

Uni-Fuels has higher revenue and earnings than Scienture.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Uni-Fuels	$263.89M	0.09	N/A	N/A	N/A
Scienture	$430K	36.85	-$41.51M	-$2.51	N/A

Scienture has a consensus target price of $1.50, indicating a potential upside of 284.62%. Given Scienture's stronger consensus rating and higher probable upside, analysts plainly believe Scienture is more favorable than Uni-Fuels.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Uni-Fuels	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Scienture	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Scienture beats Uni-Fuels on 8 of the 12 factors compared between the two stocks.

How does Scienture compare to Natural Health Trends?

Scienture (NASDAQ:SCNX) and Natural Health Trends (NASDAQ:NHTC) are both small-cap wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

5.7% of Scienture shares are held by institutional investors. Comparatively, 10.1% of Natural Health Trends shares are held by institutional investors. 21.4% of Scienture shares are held by insiders. Comparatively, 12.9% of Natural Health Trends shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Natural Health Trends has higher revenue and earnings than Scienture. Natural Health Trends is trading at a lower price-to-earnings ratio than Scienture, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scienture	$430K	36.85	-$41.51M	-$2.51	N/A
Natural Health Trends	$39.78M	0.60	-$880K	-$0.11	N/A

Scienture has a beta of 3.32, indicating that its stock price is 232% more volatile than the broader market. Comparatively, Natural Health Trends has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

Scienture has a net margin of 0.00% compared to Natural Health Trends' net margin of -3.03%. Natural Health Trends' return on equity of -4.88% beat Scienture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scienture	N/A	-56.28%	-44.76%
Natural Health Trends	-3.03%	-4.88%	-2.94%

Scienture presently has a consensus price target of $1.50, suggesting a potential upside of 284.62%. Given Scienture's stronger consensus rating and higher possible upside, equities analysts plainly believe Scienture is more favorable than Natural Health Trends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scienture	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Natural Health Trends	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Scienture had 2 more articles in the media than Natural Health Trends. MarketBeat recorded 2 mentions for Scienture and 0 mentions for Natural Health Trends. Scienture's average media sentiment score of 0.75 beat Natural Health Trends' score of 0.00 indicating that Scienture is being referred to more favorably in the media.

Company	Overall Sentiment
Scienture	Positive
Natural Health Trends	Neutral

Summary

Scienture beats Natural Health Trends on 10 of the 16 factors compared between the two stocks.

How does Scienture compare to Creative Global Technology?

Scienture (NASDAQ:SCNX) and Creative Global Technology (NASDAQ:CGTL) are both small-cap wholesale companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Scienture has a beta of 3.32, suggesting that its share price is 232% more volatile than the broader market. Comparatively, Creative Global Technology has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market.

Scienture presently has a consensus price target of $1.50, indicating a potential upside of 284.62%. Given Scienture's stronger consensus rating and higher possible upside, research analysts clearly believe Scienture is more favorable than Creative Global Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scienture	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Creative Global Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Creative Global Technology has higher revenue and earnings than Scienture.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scienture	$430K	36.85	-$41.51M	-$2.51	N/A
Creative Global Technology	$21.15M	0.32	-$13.37M	N/A	N/A

5.7% of Scienture shares are owned by institutional investors. 21.4% of Scienture shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Creative Global Technology's return on equity of 0.00% beat Scienture's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scienture	N/A	-56.28%	-44.76%
Creative Global Technology	N/A	N/A	N/A

In the previous week, Scienture had 2 more articles in the media than Creative Global Technology. MarketBeat recorded 2 mentions for Scienture and 0 mentions for Creative Global Technology. Scienture's average media sentiment score of 0.75 beat Creative Global Technology's score of 0.00 indicating that Scienture is being referred to more favorably in the media.

Company	Overall Sentiment
Scienture	Positive
Creative Global Technology	Neutral

Summary

Scienture beats Creative Global Technology on 9 of the 13 factors compared between the two stocks.

Get Scienture News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SCNX vs. The Competition

Export

Metric	Scienture	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$15.99M	$2.99B	$6.25B	$12.23B
Dividend Yield	N/A	1.96%	2.80%	5.27%
P/E Ratio	-0.16	17.04	20.79	25.04
Price / Sales	36.85	251.21	531.21	72.18
Price / Cash	N/A	57.15	43.09	54.25
Price / Book	0.24	4.39	9.81	6.83
Net Income	-$41.51M	$74.99M	$3.55B	$335.69M
7 Day Performance	-1.99%	-4.89%	-2.07%	-2.03%
1 Month Performance	-1.27%	-8.30%	-3.90%	-1.90%
1 Year Performance	-58.90%	28.66%	29.39%	27.36%

Scienture Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SCNX Scienture	3.1367 of 5 stars	$0.39 -0.9%	$1.50 +284.6%	-55.8%	$15.99M	$430K	N/A	N/A	News Coverage
RAVE Rave Restaurant Group	1.4293 of 5 stars	$2.67 -5.3%	N/A	-4.8%	$37.94M	$12.04M	13.35	20
LTCH Latch	N/A	$0.20 -16.7%	N/A	+71.4%	$32.85M	$48.39M	N/A	420	High Trading Volume
UFG Uni-Fuels	1.2379 of 5 stars	$0.84 -5.7%	N/A	N/A	$27.24M	$263.89M	N/A	17	Negative News
NHTC Natural Health Trends	0.512 of 5 stars	$3.10 +0.3%	N/A	-42.1%	$26.60M	$39.78M	N/A	140	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SCNX) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Scienture (SCNX) Competitors

SCNX vs. RAVE, LTCH, UFG, NHTC, and CGTL

How does Scienture compare to Rave Restaurant Group?

Summary

How does Scienture compare to Latch?

Summary

How does Scienture compare to Uni-Fuels?

Summary

How does Scienture compare to Natural Health Trends?

Summary

How does Scienture compare to Creative Global Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SCNX vs. The Competition

Scienture Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Scienture (SCNX) Competitors

SCNX vs. RAVE, LTCH, UFG, NHTC, and CGTL

How does Scienture compare to Rave Restaurant Group?

Do institutionals and insiders have more ownership in RAVE or SCNX?

Which has higher earnings and valuation, RAVE or SCNX?

Is RAVE or SCNX more profitable?

Which has more risk and volatility, RAVE or SCNX?

Do analysts recommend RAVE or SCNX?

Does the media prefer RAVE or SCNX?

Summary

How does Scienture compare to Latch?

Which has higher earnings and valuation, LTCH or SCNX?

Is LTCH or SCNX more profitable?

Do analysts rate LTCH or SCNX?

Do institutionals & insiders believe in LTCH or SCNX?

Which has more volatility & risk, LTCH or SCNX?

Does the media favor LTCH or SCNX?

Summary

How does Scienture compare to Uni-Fuels?

Does the media refer more to UFG or SCNX?

Do institutionals and insiders have more ownership in UFG or SCNX?

Which has more risk & volatility, UFG or SCNX?

Is UFG or SCNX more profitable?

Which has better valuation & earnings, UFG or SCNX?

Do analysts rate UFG or SCNX?

Summary

How does Scienture compare to Natural Health Trends?

Do insiders & institutionals believe in SCNX or NHTC?

Which has preferable earnings & valuation, SCNX or NHTC?

Which has more volatility and risk, SCNX or NHTC?

Is SCNX or NHTC more profitable?

Do analysts prefer SCNX or NHTC?

Does the media prefer SCNX or NHTC?

Summary

How does Scienture compare to Creative Global Technology?

Which has more volatility and risk, SCNX or CGTL?

Do analysts rate SCNX or CGTL?

Which has higher valuation & earnings, SCNX or CGTL?

Do institutionals & insiders have more ownership in SCNX or CGTL?

Is SCNX or CGTL more profitable?

Does the media prefer SCNX or CGTL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SCNX vs. The Competition

Scienture Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools